Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
Rheinmetall Aktiengesellschaft: A reportable insider transaction was published on 13th August 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 13th August 2025,
The Insider Transaction was made by Draeger, Dr.-Ing. Klaus 
. The transaction toke place on 12th August 2025. The order was executed at the trading place XETRA. . The aggregated volume was 248.745,00 EUR, based on an average price of 1.545,00 EUR. The nature of the Investment was Buy.
Jost Aktiengesellschaft: A reportable insider transaction was published on 3rd July 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 3rd July 2025,
The Insider Transaction was made by Jost, Klaus . The transaction toke place on 2nd July 2025. The order was executed at the trading place Stuttgart STUB. . The aggregated volume was 1.388,00 EUR, based on an average price of 7,00 EUR. The nature of the Investment was Sell.
Viromed Medical AG: A reportable insider transaction was published on 6th June 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 6th June 2025,
The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 6th June 2025. . The aggregated volume was 1.000.000,00 EUR, based on an average price of 4,00 EUR. The nature of the Investment was Sell.
RENK Group AG: A reportable insider transaction was published on 23rd May 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 23rd May 2025,
The Insider Transaction was made by Stahlmann, Klaus . The transaction toke place on 22nd May 2025. The order was executed at the trading place Tradegate. . The aggregated volume was 2.100.000,00 EUR, based on an average price of 70,00 EUR. The nature of the Investment was Sell.
Allianz SE: A reportable insider transaction was published on 19th May 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 19th May 2025,
The Insider Transaction was made by Röhler, Dr. Klaus-Peter . The transaction toke place on 12th May 2025. . The aggregated volume was 50.914,81 EUR, based on an average price of 358,56 EUR. The nature of the Investment was not specified.
Knorr-Bremse Aktiengesellschaft: A reportable insider transaction was published on 19th May 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 19th May 2025,
The Insider Transaction was made by Lange, Dr. Nicolas . The transaction toke place on 15th May 2025. The order was executed at the trading place XETRA. . The aggregated volume was 350.023,50 EUR, based on an average price of 86,98 EUR. The nature of the Investment was Buy.
Siltronic AG: A reportable insider transaction was published on 13th May 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 13th May 2025,
The Insider Transaction was made by Buchwald, Klaus . The transaction toke place on 9th May 2025. The order was executed at the trading place XETRA. . The aggregated volume was 3.790,00 EUR, based on an average price of 37,90 EUR. The nature of the Investment was not specified.
LPKF Laser & Electronics SE: A reportable insider transaction was published on 2nd May 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 2nd May 2025,
The Insider Transaction was made by Fiedler, Dr. Klaus . The transaction toke place on 30th April 2025. . The aggregated volume was 20.175,00 EUR, based on an average price of 8,07 EUR. The nature of the Investment was Buy.
Viromed Medical AG: A reportable insider transaction was published on 23rd April 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 23rd April 2025,
The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 17th April 2025. . The aggregated volume was 440.000,00 EUR, based on an average price of 4,40 EUR. The nature of the Investment was Sell.
RENK Group AG: A reportable insider transaction was published on 17th April 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 17th April 2025,
The Insider Transaction was made by Stahlmann, Klaus . The transaction toke place on 16th April 2025. The order was executed at the trading place Tradegate. . The aggregated volume was 1.507.117,90 EUR, based on an average price of 50,11 EUR. The nature of the Investment was Sell.
Schaeffler AG: A reportable insider transaction was published on 31st March 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 31st March 2025,
The Insider Transaction was made by Wagner, Uwe . The transaction toke place on 28th March 2025. The order was executed at the trading place Tradegate. . The aggregated volume was 40.092,20 EUR, based on an average price of 4,01 EUR. The nature of the Investment was Buy.
Rheinmetall Aktiengesellschaft: A reportable insider transaction was published on 14th March 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 14th March 2025,
The Insider Transaction was made by Vennemann, Klaus-Günter . The transaction toke place on 14th March 2025. The order was executed at the trading place Xetra. . The aggregated volume was 6.205.400,00 EUR, based on an average price of 1.349,00 EUR. The nature of the Investment was Sell.
Siltronic AG: A reportable insider transaction was published on 13th March 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 13th March 2025,
The Insider Transaction was made by Buchwald, Klaus . The transaction toke place on 11th March 2025. The order was executed at the trading place Tradegate (Best Execution). . The aggregated volume was 86.231,90 EUR, based on an average price of 43,12 EUR. The nature of the Investment was not specified.
Schaeffler AG: A reportable insider transaction was published on 13th March 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 13th March 2025,
The Insider Transaction was made by Wagner, Uwe . The transaction toke place on 12th March 2025. The order was executed at the trading place Tradegate. . The aggregated volume was 100.314,80 EUR, based on an average price of 4,18 EUR. The nature of the Investment was Buy.
Viromed Medical AG: A reportable insider transaction was published on 12th March 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 12th March 2025,
The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 10th March 2025. The order was executed at the trading place Xetra. . The aggregated volume was 16.920,00 EUR, based on an average price of 1,88 EUR. The nature of the Investment was Buy.
RENK Group AG: A reportable insider transaction was published on 11th February 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 11th February 2025,
The Insider Transaction was made by Stahlmann, Klaus . The transaction toke place on 10th February 2025. . The aggregated volume was 3.451.185,00 EUR, based on an average price of 15,00 EUR. The nature of the Investment was not specified.
Viromed Medical AG: A reportable insider transaction was published on 7th February 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 7th February 2025,
The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 5th February 2025. The order was executed at the trading place Xetra. . The aggregated volume was 23.260,00 EUR, based on an average price of 1,93 EUR. The nature of the Investment was Buy.
Viromed Medical AG: A reportable insider transaction was published on 7th February 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 7th February 2025,
The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 5th February 2025. The order was executed at the trading place Xetra. . The aggregated volume was 23.260,00 EUR, based on an average price of 1,93 EUR. The nature of the Investment was Buy.
Viromed Medical AG: A reportable insider transaction was published on 7th February 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 7th February 2025,
The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 5th February 2025. The order was executed at the trading place Xetra. . The aggregated volume was 23.260,00 EUR, based on an average price of 1,93 EUR. The nature of the Investment was Buy.
Viromed Medical AG: A reportable insider transaction was published on 7th February 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 7th February 2025,
The Insider Transaction was made by Perbandt, Uwe . The transaction toke place on 5th February 2025. The order was executed at the trading place Xetra. . The aggregated volume was 23.260,00 EUR, based on an average price of 1,93 EUR. The nature of the Investment was Buy.
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.